AI assistant
Sending…
Imunon, Inc. — Director's Dealing 2021
Oct 8, 2021
35124_dirs_2021-10-08_7b68d070-06c4-49bf-8da3-23fc2cdb71a4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2021-10-07
Reporting Person: Fritz Frederick J. (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-10-07 | Celsion Corporation Common Stock | P | 20000 | $0.88 | Acquired | 71491 | Direct |
Footnotes
F1: The shares were purchased on the open market.
More from Imunon, Inc.
Capital/Financing Update
2026
Jun 4
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Annual Report
2026
May 4
Regulatory Filings
2026
May 4
Proxy Solicitation & Information Statement
2026
May 4
Annual Report
2026
Mar 31
Regulatory Filings
2026
Mar 31
Capital/Financing Update
2026
Mar 23
Regulatory Filings
2026
Mar 23